Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VMD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Director Sabrina Heltz Received 20.2% Opposition (new) — Elevated vote withholding compared to other directors may signal shareholder concerns about this board member's qualifications or performance.
Viemed shareholders approve equity plan expansion to 7.7M shares, elect all directors
Filed June 4, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
medium
Shareholders approved expansion of 2024 Long Term Incentive Plan to 7,696,717 total shares (including up to 1M incentive stock options) with 88.9% support, providing additional capacity for employee equity compensation.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Director Sabrina Heltz elected with 79.8% support versus 93.3%–97.7% for other six directors; 20.2% of votes withheld represents elevated opposition compared to board peers.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
medium
Say-on-pay vote passed with 93.2% support (6.2% against), indicating strong shareholder endorsement of executive compensation practices.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
low
Ernst & Young LLP approved as independent auditor for fiscal 2026 with 97.6% support, a routine annual ratification.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
Summary
Viemed Healthcare held its annual shareholder meeting on June 4, 2026, with shareholders approving all major proposals. The most material outcome was approval of the Second Amendment to the 2024 Long Term Incentive Plan, which expands the total share reserve across all equity plans to 7,696,717 common shares.
The amendment passed with 88.9% support, providing management with additional capacity to grant equity compensation to employees and executives. All seven director nominees were elected, though voting results revealed a notable disparity.
Six directors received strong support ranging from 93.3% to 97.7%, while Sabrina Heltz faced elevated opposition with 20.2% of votes withheld—more than triple the opposition faced by most peers. This level of dissent warrants attention as it may reflect shareholder concerns about her board service. The say-on-pay vote passed comfortably at 93.2%, indicating general satisfaction with executive compensation practices. Ernst & Young's reappointment as auditor was routine. Investors should monitor whether the board addresses the concerns underlying Heltz's elevated opposition, and watch how management deploys the expanded equity pool given the dilutive impact on existing shareholders.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Annual shareholder meeting results: all seven directors elected, auditor appointed, compensation plan amendment and say-on-pay approved.
Added in current filing · verify on EDGAR →
Shareholders approved an ordinary resolution to ratify, confirm, and approve the Second Amendment to the 2024 LTIP. The voting results were as follows:
Votes For% For Votes Against | % Against | Abstain Broker Non-Votes
19,888,04688.85%2,267,64010.13%227,8675,139,306
The Second Amendment to the 2024 Long-Term Incentive Plan was approved with 88.9% of votes cast in favor and 10.1% against. The amendment received lower support than the auditor appointment but passed with a comfortable majority.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify